# A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization

> **NCT07527741** · — · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 100 (estimated)

## Conditions studied

- Early-stage HER2+ Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07527741
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-23
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07527741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07527741, "A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07527741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*